Bessemer Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-118
| Closed | -$12K | – | 2474 |
|
|
2025
Q2 | $12K | Buy |
118
+15
| +15% | +$1.42K | ﹤0.01% | 1732 |
|
|
2025
Q1 | $10K | Sell |
103
-11
| -10% | -$1.01K | ﹤0.01% | 1754 |
|
|
2024
Q4 | $10K | Buy |
114
+26
| +30% | +$2.39K | ﹤0.01% | 1748 |
|
|
2024
Q3 | $9K | Buy |
88
+14
| +19% | +$1.37K | ﹤0.01% | 1695 |
|
|
2024
Q2 | $6K | Sell |
74
-756
| -91% | -$70.1K | ﹤0.01% | 1639 |
|
|
2024
Q1 | $76K | Sell |
830
-349
| -30% | -$32.7K | ﹤0.01% | 1222 |
|
|
2023
Q4 | $112K | Hold |
1,179
| – | – | ﹤0.01% | 1186 |
|
|
2023
Q3 | $110K | Buy |
1,179
+72
| +7% | +$6.65K | ﹤0.01% | 1170 |
|
|
2023
Q2 | $101K | Buy |
1,107
+27
| +3% | +$2.21K | ﹤0.01% | 1219 |
|
|
2023
Q1 | $79K | Buy |
+1,080
| New | +$93.4K | ﹤0.01% | 1131 |
|
|
2022
Q4 | – | Sell |
-101,992
| Closed | -$9.2M | – | 1859 |
|
|
2022
Q3 | $9.87M | Buy |
101,992
+31,417
| +45% | +$3.75M | 0.03% | 244 |
|
|
2022
Q2 | $7.42M | Buy |
+70,575
| New | +$9.02M | 0.02% | 252 |
|
|
2022
Q1 | – | Sell |
-22
| Closed | -$4K | – | 1818 |
|
|
2021
Q4 | $4K | Sell |
22
-21
| -49% | -$3.38K | ﹤0.01% | 1617 |
|
|
2021
Q3 | $6K | Sell |
43
-4
| -9% | -$832 | ﹤0.01% | 1467 |
|
|
2021
Q2 | $12K | Buy |
+47
| New | +$12.3K | ﹤0.01% | 1305 |
|
|
2020
Q1 | – | Sell |
-50
| Closed | -$8K | – | 1605 |
|
|
2019
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 1450 |
|
|
2019
Q3 | $7K | Buy |
+50
| New | +$6.51K | ﹤0.01% | 1511 |
|
|
2019
Q2 | – | Sell |
-9,000
| Closed | -$1.11M | – | 1631 |
|
|
2019
Q1 | $1.11M | Sell |
9,000
-900
| -9% | -$113K | ﹤0.01% | 610 |
|
|
2018
Q4 | $1.16M | Buy |
9,900
+1,700
| +21% | +$200K | 0.01% | 538 |
|
|
2018
Q3 | $1.02M | Buy |
+8,200
| New | +$906K | ﹤0.01% | 575 |
|
Other funds holding AMED
IA
MCI
HNB
Bessemer Group's AMED Position: Q3 2025 in Review
Bessemer Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 118 shares — an estimated $12K sold.
Bessemer Group first reported a position in AMED in Q3 2018 and held it in 20 quarters. The position peaked at $9.87M in Q3 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Bessemer Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Bessemer Group sold 118 Amedisys shares in Q3 2025, an estimated $12K.
- Bessemer Group first reported a position in Amedisys in Q3 2018 and held it in 20 quarters.
- Bessemer Group's Amedisys position peaked at $9.87M in Q3 2022.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.